Your browser doesn't support javascript.
loading
Impact of early interferon-ß treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort.
Salto-Alejandre, Sonsoles; Palacios-Baena, Zaira R; Arribas, José Ramón; Berenguer, Juan; Carratalà, Jordi; Jarrín, Inmaculada; Ryan, Pablo; Miguel-Montero, Marta de; Rodríguez-Baño, Jesús; Pachón, Jerónimo.
Afiliação
  • Salto-Alejandre S; Unit of Infectious Diseases, Microbiology and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain.
  • Palacios-Baena ZR; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Unit of Infectious Diseases and Microbiology, University Hospital Virgen Macarena, Seville, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos I
  • Arribas JR; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Unit of Infectious Diseases, Service of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain.
  • Berenguer J; Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain; Service of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Carratalà J; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Service of Infectious Diseases, Hospital Universitario de Bellvitge, Barcelona, Spain; Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
  • Jarrín I; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.
  • Ryan P; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; Service of Internal Medicine, Hospital Universitario Infanta Leonor, Madrid, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Miguel-Montero M; Fundación SEIMC/GeSIDA, Madrid, Spain.
  • Rodríguez-Baño J; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Unit of Infectious Diseases and Microbiology, University Hospital Virgen Macarena, Seville, Spain; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos I
  • Pachón J; Unit of Infectious Diseases, Microbiology and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville, Virgen del Rocío and Virgen Macarena University Hospitals/CSIC/University of Seville, Seville, Spain; Department of Medicine, Universidad de S
Biomed Pharmacother ; 146: 112572, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34954640
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Interferon beta / Tempo para o Tratamento / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Interferon beta / Tempo para o Tratamento / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha